Article R5141-123-8
I. - The veterinary medicinal product for which parallel import authorisation is requested may differ from the veterinary medicinal product which has obtained marketing authorisation in France, provid…
20+ full codes, 2,400+ articles translated and updated. Case law linked to every article. Read the actual text before you ask a lawyer about it — free, no login required.
20+
french codes
Fully translated
2,400+
articles in English
Updated regularly
480+
court rulings linked
Per article
Free
full access
No login required
Showing 3301–3310 of 26472 articles for “Art. Cass. com. – 9 July 2013 – no. 12-20.468”
I. - The veterinary medicinal product for which parallel import authorisation is requested may differ from the veterinary medicinal product which has obtained marketing authorisation in France, provid…
Except where human or animal health grounds preclude it, parallel import authorisation is granted if the following conditions are met:1° The veterinary medicinal product is obtained from a company aut…
Silence on the part of the Director General of the Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail shall constitute refusal of authorisation on expiry of a p…
I.-A proprietary veterinary medicinal product may be imported in parallel with a view to being placed on the market in France if it meets the following conditions: 1° It comes from another Member Stat…
The holder of the parallel import authorisation is responsible for placing the product on the market and, in this capacity, ensures that the provisions of this Title are complied with, in particular t…
When the Director General of the Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail notifies the holder of the parallel import authorisation for a proprietary v…
When a company mentioned in article R. 5142-1 plans to close one of its establishments authorised in application of the provisions of article R. 5142-5, it informs the Agence nationale de sécurité san…
…ons relating to them respectively, which are set out in articles R. 5132-78, R. 5132-27 and R. 5132-91.
…der in the country of origin of any serious adverse reaction, within the meaning of Article R. 5141-92, concerning the imported proprietary medicinal product, as soon as he is aware of it.
For its application to La Réunion and Mayotte, in article R. 6123-27, after the words "infra-regional", the words "Mahorais, common to La Réunion and Mayotte" are added.
Avocate au Barreau de Paris
Toque #C2396
15+ Years In French Corporate Practice
English · French · Russian
Ready When You Are
A 20–30 minute call, in English, to scope the engagement. No obligation, no preliminary fee. You will leave the call with a clear view of what the work will cover and what it will cost.
20+ full codes and 2,400+ articles in English, with the key court rulings linked to every article — free to read.
Read MoreA lawyer-reviewed report explaining how the relevant articles apply to your situation, with case-law analysis and next steps.
Read MoreScope your matter with a Paris-Bar avocate — incorporation, contracts, disputes — handled bilingually, end to end.
Read More